Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease

TW202633594APending Publication Date: 2026-08-16MALLINCKRODT PHARMACEUTICALS IRELAND LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114150988
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2017-12-28
Filing Date
2018-08-30
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001073309_001
    Figure TWG2TA001073309_001
  • Figure TWG2TA001073309_002
    Figure TWG2TA001073309_002
  • Figure TWG2TA001073309_003
    Figure TWG2TA001073309_003
Patent Text Reader

Abstract

Described herein are methods of using inhaled nitric oxide for treating pulmonary hypertension and / or improving oxygen saturation in a patient with a ventilation-perfusion (V / Q) mismatch and / or pulmonary hypertension associated with lung disease.
Need to check novelty before this filing date? Find Prior Art